Literature DB >> 8015797

Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS.

M Glick1, B C Muzyka, D Lurie, L M Salkin.   

Abstract

BACKGROUND: Oral lesions are common findings in HIV-related disease, but little is known about their significance in predicting immune suppression among a representative group of HIV-infected persons.
METHODS: Oral examinations were performed on 454 patients who came to an outpatient dental clinic for dental care. CD4+ cell counts were obtained within 2 months of the examination.
RESULTS: In persons with a specific lesion and a CD4+ cell count below 200 cells/mm3 the corresponding mean CD4+ cell counts and predictive values were 149.5 cells/mm3 and 69.9% for candidiasis, 143.3 cells/mm3 and 70.1% for oral hairy leukoplakia, 126.0 cells/mm3 and 69.4% for xerostomia, 51.8 cells/mm3 and 95.1% for necrotizing ulcerative periodontitis, 98.7 cells/mm3 and 87.0% for long-standing herpes simplex virus infections, 66.6 cells/mm3 and 93.6% for Kaposi's sarcoma, and 33.7 cells/mm3 and 100% for major aphthous ulcers. The mean CD4+ cell count declined with increased numbers of different concurrent lesions.
CONCLUSION: The presence of specific oral manifestations and the number of different concurrent intraoral lesions among HIV-infected persons are associated with severe immune suppression and AIDS. Oral examinations are an essential component for early recognition of disease progression and comprehensive evaluation of HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8015797     DOI: 10.1016/0030-4220(94)90195-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol        ISSN: 0030-4220


  29 in total

Review 1.  The significance of oral health in HIV disease.

Authors:  I L Chapple; J Hamburger
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

2.  Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  Wipawee Nittayananta; Marisa Kemapunmanus; Korntip Amornthatree; Sineepat Talungchit; Hutcha Sriplung
Journal:  J Oral Pathol Med       Date:  2012-06-09       Impact factor: 4.253

3.  Dermatologic manifestations as indicators of immune status in HIV/AIDS.

Authors:  Tamsin H Levy; David F Jacobson
Journal:  J Gen Intern Med       Date:  2011-06-07       Impact factor: 5.128

4.  Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.

Authors:  C H Shiboski; H Chen; M A Ghannoum; L Komarow; S Evans; P K Mukherjee; N Isham; D Katzenstein; A Asmelash; A E Omozoarhe; S Gengiah; R Allen; S Tripathy; S Swindells
Journal:  Int J Tuberc Lung Dis       Date:  2014-06       Impact factor: 2.373

5.  Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa.

Authors:  Elaine Blignaut; Claude Pujol; Shawn Lockhart; Sophie Joly; David R Soll
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 6.  Overview of the oral HIV/AIDS Research Alliance Program.

Authors:  C H Shiboski; J Y Webster-Cyriaque; M Ghannoum; J S Greenspan; D Dittmer
Journal:  Adv Dent Res       Date:  2011-04

7.  Oral manifestations as predictors of immune suppression in a HIV-/AIDS-infected population in south India.

Authors:  Gaurav Sharma; Keerthilatha M Pai; Suhas Setty; John T Ramapuram; Archna Nagpal
Journal:  Clin Oral Investig       Date:  2008-07-31       Impact factor: 3.573

8.  Oral manifestations in human immunodeficiency virus infected patients.

Authors:  Sumit Sen; Sukanta Mandal; Sourav Bhattacharya; Saswati Halder; Parna Bhaumik
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

9.  Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  W Nittayananta; K Amornthatree; M Kemapunmanus; S Talungchit; H Sriplung
Journal:  Oral Dis       Date:  2013-05-30       Impact factor: 3.511

10.  Changes in oral cytokeratin expression in HIV-infected subjects with long-term use of HAART.

Authors:  W Nittayananta; W Mitarnun; S Talungchit; H Sriplung
Journal:  Oral Dis       Date:  2012-07-02       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.